Free Trial

Fennec Pharmaceuticals (FENC) Earnings Date, Estimates & Call Transcripts

Fennec Pharmaceuticals logo
$4.48 +0.25 (+5.91%)
(As of 11/13/2024 ET)

Fennec Pharmaceuticals Latest Earnings Summary

Upcoming Q3
Earnings Date
Mar. 20Estimated
Actual EPS
(Aug. 13)
-$0.20 Missed By -$0.26
Consensus EPS
(Aug. 13)
$0.06

Fennec Pharmaceuticals issued Q2 2024 earnings on August 13, 2024, reporting an EPS of -$0.20, which missed analysts' consensus estimates of $0.06 by $0.26. Quarterly revenue was reported to be $7.26 million, below the consensus estimate of $13.67 million. With a trailing EPS of -$0.10, Fennec Pharmaceuticals' earnings are expected to decrease -37.50% next year, from $0.08 to $0.05 per share.

FENC Upcoming Earnings

Fennec Pharmaceuticals' next earnings date is estimated for Thursday, March 20, 2025, based off prior year's reporting schedules.

Get Fennec Pharmaceuticals Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Fennec Pharmaceuticals and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

FENC Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

FENC Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Fennec Pharmaceuticals Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20242-$0.05-$0.02-$0.04
Q2 20243-$0.17$0.42$0.06
Q3 20243-$0.16$0.24-$0.01
Q4 20243-$0.13$0.28$0.06
FY 202411-$0.51$0.92$0.07
Q1 20253-$0.02$0.09$0.04
Q2 20253$0.00$0.55$0.25
Q3 20253$0.04$1.27$0.52
Q4 20253$0.05$2.56$0.98
FY 202512$0.07$4.47$1.79

Fennec Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
3/20/2025
(Estimated)
------- 
8/13/2024Q2 2024$0.06-$0.20 -$0.26-$0.20$13.67M$7.26M      
5/14/2024Q1 2024$0.49$0.41 -$0.08$0.41$10.46M$25.38M      
3/21/2024Q4 2023$0.02-$0.10 -$0.12-$0.10$9.47M$9.74M  
11/6/2023Q3 2023-$0.11-$0.07+$0.04-$0.07$5.22M$6.52M      
8/3/2023Q2 2023-$0.18-$0.21 -$0.03-$0.21$4.01M$3.33M  
5/11/2023Q1 2023-$0.21-$0.23 -$0.02-$0.23$1.88M$1.68M  
3/30/2023Q4 2022-$0.24-$0.26 -$0.02-$0.26$1.97M$1.54M

Fennec Pharmaceuticals Earnings - Frequently Asked Questions

Fennec Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 20th, 2025 based off last year's report dates. Learn more on FENC's earnings history.

In the previous quarter, Fennec Pharmaceuticals (NASDAQ:FENC) missed the analysts' consensus estimate of $0.06 by $0.26 with a reported earnings per share (EPS) of ($0.20). Learn more on analysts' earnings estimate vs. FENC's actual earnings.

The conference call for Fennec Pharmaceuticals's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Fennec Pharmaceuticals's latest earnings report can be read online.
Read Transcript

Fennec Pharmaceuticals (NASDAQ:FENC) has a recorded annual revenue of $48.89 million.

Fennec Pharmaceuticals (NASDAQ:FENC) has a recorded net income of -$16.05 million. FENC has generated -$0.10 earnings per share over the last four quarters.

Fennec Pharmaceuticals's earnings are expected to decrease from $0.08 per share to $0.05 per share in the next year, which is a -37.50% change.

`

More Earnings Resources from MarketBeat



This page (NASDAQ:FENC) was last updated on 11/13/2024 by MarketBeat.com Staff
From Our Partners